NUR-635 PHARM FINAL EXAM 2026–
2027
(140 QUESTIONS AND CORRECT
ANSWERS)
ALREADY GRADED A+ | 100%
VERIFIED
Advanced Education & Nursing | Grand Canyon University (GCU)
Key Domains: Advanced Pharmacology, Pharmacokinetics, Pharmacodynamics, Drug
Classifications, Clinical Therapeutics, Adverse Effects, and Evidence-Based Prescribing
Expert-Aligned Structure | Exam-Ready Format
Introduction
This structured NUR-635 Pharm Final Exam format for 2026–2027 provides the complete
layout for generating high-quality exam-style questions with correct answers and
rationales. It emphasizes advanced pharmacological principles, clinical therapeutics,
adverse effect management, and evidence-based prescribing critical to professional
advanced practice nursing and successful Grand Canyon University course completion.
Answer Format
All correct answers appear in bold and cyan, accompanied by concise rationales explaining
safety/clinical reasoning, code adherence, and why alternative options are less appropriate.
,Question 1: Which phase of pharmacokinetics involves the movement of drugs from the
bloodstream to target tissues?
• A. Absorption
• B. Distribution
• C. Metabolism
• D. Excretion
Correct Answer: B
Rationale: Distribution is the phase where drugs move from the bloodstream to tissues and
organs throughout the body.
Question 2: What is the primary site of drug metabolism?
• A. Kidneys
• B. Liver
• C. Lungs
• D. Intestines
Correct Answer: B
Rationale: The liver is the primary site of drug metabolism, where enzymes (especially
cytochrome P450) biotransform drugs into more water-soluble metabolites.
Question 3: Bioavailability refers to:
• A. The amount of drug excreted in urine
• B. The fraction of administered drug that reaches systemic circulation unchanged
• C. The rate of drug absorption
• D. The volume of distribution
Correct Answer: B
Rationale: Bioavailability is the fraction (or percentage) of an administered drug dose that
reaches the systemic circulation in an unchanged form.
Question 4: Which route of administration has 100% bioavailability?
• A. Oral
• B. Sublingual
• C. Intravenous
• D. Intramuscular
,Correct Answer: C
Rationale: Intravenous administration delivers drugs directly into the bloodstream,
bypassing absorption barriers, resulting in 100% bioavailability.
Question 5: The therapeutic index (TI) is calculated as:
• A. ED50/TD50
• B. TD50/ED50
• C. LD50/ED50
• D. ED90/TD10
Correct Answer: B
Rationale: Therapeutic Index = TD50/ED50 (toxic dose for 50% of population divided by
effective dose for 50%). A higher TI indicates a safer drug.
, Question 6: First-pass metabolism primarily affects drugs administered via which route?
• A. Intravenous
• B. Oral
• C. Sublingual
• D. Transdermal
Correct Answer: B
Rationale: Oral drugs pass through the portal circulation to the liver before reaching
systemic circulation, undergoing significant first-pass metabolism.
Question 7: Which factor does NOT affect drug absorption?
• A. pH of the environment
• B. Blood flow to the site
• C. Drug's color
• D. Surface area available
Correct Answer: C
Rationale: Drug color does not affect absorption. pH, blood flow, surface area, drug
formulation, and concentration gradients all influence absorption.
Question 8: Volume of distribution (Vd) indicates:
• A. The actual volume of blood in the body
• B. The apparent volume into which a drug distributes
• C. The rate of drug elimination
• D. The amount of drug in the liver
Correct Answer: B
Rationale: Vd is a theoretical volume representing how extensively a drug distributes
throughout the body relative to plasma concentration.
Question 9: Half-life (t½) is defined as:
• A. Time for complete drug elimination
• B. Time for plasma drug concentration to decrease by 50%
• C. Time for drug to reach steady state
• D. Time for maximum drug effect
2027
(140 QUESTIONS AND CORRECT
ANSWERS)
ALREADY GRADED A+ | 100%
VERIFIED
Advanced Education & Nursing | Grand Canyon University (GCU)
Key Domains: Advanced Pharmacology, Pharmacokinetics, Pharmacodynamics, Drug
Classifications, Clinical Therapeutics, Adverse Effects, and Evidence-Based Prescribing
Expert-Aligned Structure | Exam-Ready Format
Introduction
This structured NUR-635 Pharm Final Exam format for 2026–2027 provides the complete
layout for generating high-quality exam-style questions with correct answers and
rationales. It emphasizes advanced pharmacological principles, clinical therapeutics,
adverse effect management, and evidence-based prescribing critical to professional
advanced practice nursing and successful Grand Canyon University course completion.
Answer Format
All correct answers appear in bold and cyan, accompanied by concise rationales explaining
safety/clinical reasoning, code adherence, and why alternative options are less appropriate.
,Question 1: Which phase of pharmacokinetics involves the movement of drugs from the
bloodstream to target tissues?
• A. Absorption
• B. Distribution
• C. Metabolism
• D. Excretion
Correct Answer: B
Rationale: Distribution is the phase where drugs move from the bloodstream to tissues and
organs throughout the body.
Question 2: What is the primary site of drug metabolism?
• A. Kidneys
• B. Liver
• C. Lungs
• D. Intestines
Correct Answer: B
Rationale: The liver is the primary site of drug metabolism, where enzymes (especially
cytochrome P450) biotransform drugs into more water-soluble metabolites.
Question 3: Bioavailability refers to:
• A. The amount of drug excreted in urine
• B. The fraction of administered drug that reaches systemic circulation unchanged
• C. The rate of drug absorption
• D. The volume of distribution
Correct Answer: B
Rationale: Bioavailability is the fraction (or percentage) of an administered drug dose that
reaches the systemic circulation in an unchanged form.
Question 4: Which route of administration has 100% bioavailability?
• A. Oral
• B. Sublingual
• C. Intravenous
• D. Intramuscular
,Correct Answer: C
Rationale: Intravenous administration delivers drugs directly into the bloodstream,
bypassing absorption barriers, resulting in 100% bioavailability.
Question 5: The therapeutic index (TI) is calculated as:
• A. ED50/TD50
• B. TD50/ED50
• C. LD50/ED50
• D. ED90/TD10
Correct Answer: B
Rationale: Therapeutic Index = TD50/ED50 (toxic dose for 50% of population divided by
effective dose for 50%). A higher TI indicates a safer drug.
, Question 6: First-pass metabolism primarily affects drugs administered via which route?
• A. Intravenous
• B. Oral
• C. Sublingual
• D. Transdermal
Correct Answer: B
Rationale: Oral drugs pass through the portal circulation to the liver before reaching
systemic circulation, undergoing significant first-pass metabolism.
Question 7: Which factor does NOT affect drug absorption?
• A. pH of the environment
• B. Blood flow to the site
• C. Drug's color
• D. Surface area available
Correct Answer: C
Rationale: Drug color does not affect absorption. pH, blood flow, surface area, drug
formulation, and concentration gradients all influence absorption.
Question 8: Volume of distribution (Vd) indicates:
• A. The actual volume of blood in the body
• B. The apparent volume into which a drug distributes
• C. The rate of drug elimination
• D. The amount of drug in the liver
Correct Answer: B
Rationale: Vd is a theoretical volume representing how extensively a drug distributes
throughout the body relative to plasma concentration.
Question 9: Half-life (t½) is defined as:
• A. Time for complete drug elimination
• B. Time for plasma drug concentration to decrease by 50%
• C. Time for drug to reach steady state
• D. Time for maximum drug effect
